نتایج جستجو برای: cisplatin toxicity

تعداد نتایج: 143067  

Journal: :Journal of the American Society of Nephrology : JASN 1997
D Sheikh-Hamad K Timmins Z Jalali

Cisplatin administration is frequently associated with renal insufficiency and tubular dysfunction. In this article, a case of massive cisplatin overdose as a result of an accidental substitution for carboplatin is reported. The patient developed oliguric renal failure, hepatotoxicity, ototoxicity, peripheral neuropathy, blindness, and severe myelosuppression. A therapeutic trial with N-acetylc...

Journal: :Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2013
Nicole C Schmitt Edwin W Rubel

OBJECTIVE The goal of this study was to determine whether osteopontin, a molecule with a variety of biologic effects including cell death inhibition, plays an important role in protection of the inner ear and kidney from the toxic effects of the chemotherapeutic drug cisplatin. STUDY DESIGN In vivo study using a model system of cisplatin toxicity in adult mice. SETTING Virginia Merrill Bloe...

Journal: :International journal of clinical and experimental medicine 2015
Ying Zhang Zhicheng Yang Yijin Zhou Jingjing Pan Yongyuan Liu

Concurrent chemoradiotherapy has proven to be more effective on patients with advanced cervical cancer than radiotherapy alone. Although cisplatin has been recommended to be the standard agent in chemotherapy, it has some limitations in clinical use because of its strong side effects. Moreover, the optimal chemotherapy regimen remains unclear. A comprehensive electronic search was conducted via...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 1997
E Raymond H A Burris E K Rowinsky J R Eckardt G Rodriguez L Smith G Weiss D D Von Hoff

BACKGROUND The objectives were to determine the dose-limiting toxicity of topotecan in combination with cisplatin, to describe the principal toxicities, and to define the maximally-tolerated doses of the drugs in previously untreated patients with advanced non-small-cell lung carcinoma. PATIENTS AND METHODS The study was designed to evaluate escalated doses of topotecan (starting at 0.75 mg/m...

2017
Chengyi Huang Yufeng Yu

BACKGROUND Cisplatin remains one of the most active agents and is the mainstay of combination chemotherapy regimens against gingival squamous cell carcinoma. However, the efficacy of cisplatin is limited by its high toxicity and the development of drug resistance. β-elemene, isolated from the Chinese herb Rhizoma zedoariahas, is highly effective against malignancies and has low toxicity, but th...

Journal: :American journal of physiology. Cell physiology 2005
Wei Qian Manabu Nishikawa Anwarul Md Haque Masaki Hirose Masayuki Mashimo Eisuke Sato Masayasu Inoue

We studied the relationship between the mitochondrial density in the cells and the cellular sensitivity to the toxicity of cis-diaminedichloroplatinum II (cisplatin), a potent anticancer agent. Biochemical analyses revealed that the density of mitochondria in the intestinal epithelium changed markedly along its entire length. The density was the highest at the duodenum, medium at the jejunum, a...

2016
Bahram Mofid Abolfazl Razzaghdoust Amir Shahram Yousefi Kashi Hamid Reza Mirzaei

INTRODUCTION Esophageal cancer is the seventh most frequent malignancy in Iranian men and the fourth most common cancer in Iranian women. It is also among the 10 most frequent cancers in the world. Definitive chemo-radiation using cisplatin with 5-fluorouracil (5-FU) is known as the standard of care among various chemotherapy regimens used with esophageal cancer patients who are not eligible fo...

Journal: :Journal of pharmaceutical research international 2022

Cisplatin (cis-(diammine)dichloridoplatinum(II)) is the first platinum-based compound approved by United States Food and Drug Administration (FDA) (U.S.). This a first-line chemotherapeutic treatment used alone or combined with other anticancer drugs to treat broad spectrum of malignancies, cisplatin-based nano-formulations currently in clinical studies. has several drawbacks, including low aqu...

Journal: :Biological & Pharmaceutical Bulletin 2021

Background: Cisplatin is an effective chemotherapy but its main side effect, acute kidney injury, limits use. Panduratin A, a bioactive compound extracted from Boesenbergia rotunda, shows several biological activities such as anti-oxidative effects. The present study investigated the nephroprotective effect of panduratin A on cisplatin-induced renal injury. Methods: We toxicity cisplatin in bot...

Journal: :Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006
José Antonio Medina Antonio Rueda Antonio Sacchetti de Pasos Jorge Contreras Manuel Cobo Paloma Moreno Manuel Benavides Asunción Villanueva Emilio Alba

BACKGROUND AND PURPOSE This phase II study evaluated the efficacy and toxicity of weekly cisplatin along with concomitant boost accelerated radiation regimen in patients with locally advanced unresectable head and neck carcinoma. MATERIAL AND METHODS A total of 94 patients (median age, 58 years) with UICC stage III (n = 19) and IV (n = 75) cancer of the oropharynx, larynx, hypopharynx and ora...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید